Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Glaxo SmithKline

Bristol-Myers Squibb (BMS) building

BMS halts trial of hepatitis C drug on safety issues

At least one person in study thought to have developed congestive heart failure

- PMLiVE

GSK’s Olympic doping facility to research personalised medicines after Games

MRC-NIHR Phenome Centre is “phenomenal legacy” from London 2012 says MRC’s Prof John Savill

GSK and other Olympic sponsors may face hacking attack

IT security firm claims ‘hacktivist’ network Anonymous could target websites of London 2012 partners

GSK pay $3bn to settle drug-marketing case

UK drug-maker pleads guilty for promoting a number of drugs in the US off-label

- PMLiVE

Q&A – Catherine Oliver, managing director, Red Door Communications

Where are they now? Communiqué Awards Young Achiever winner 2004

Interview: Dan Mathews on pharma marketing trends and the PMEA programme

The chair of judges for PMEA 2012 examines the current and future challenges for the sector

- PMLiVE

Interview: Dan Mathews on pharma marketing trends and the PMEA programme

The chair of judges for PMEA 2012 examines the current and future challenges for the sector

- PMLiVE

Interview: Joseph Jimenez, Novartis

Novartis' CEO tells Linda Banks how investing in innovation and parallel development is helping to keep the company at the forefront

- PMLiVE

Interview: Sam Pearce, Celgene

The general manager of Celgene UK and Ireland explains to Liz Wells how her entrepreneurial spirit fits well with this fast-expanding biotech

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links